{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-186261","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.804887+00:00","generated_at":"2026-05-31T15:56:11.745802+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Catalyst grants Kye exclusive Canadian rights to AGAMREE for DMD","bullets":["Kye Pharmaceuticals gets exclusive Canadian rights to commercialize AGAMREE (vamorolone) for Duchenne Muscular Dystrophy.","Catalyst will supply product; Kye responsible for Health Canada approval and all commercialization in Canada.","Catalyst receives upfront payment, plus potential reimbursement, sales milestones, and royalties from Kye.","Kye already markets Catalyst's FIRDAPSE in Canada; AGAMREE application to Health Canada expected by early 2025.","Agreement expands AGAMREE's North American footprint beyond U.S. approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-186261","json":"https://secwatch.observer/filing/0001193125-24-186261.json","markdown":"https://secwatch.observer/filing/0001193125-24-186261.md","text":"https://secwatch.observer/filing/0001193125-24-186261.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524186261/0001193125-24-186261-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524186261/d810788d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:56:11.745802+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}